|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 234.40 SEK | -0.59% |
|
-3.06% | +7.13% |
| 10:43am | AQR Capital becomes new public short seller in Getinge | FW |
| 09-08 | Espiria Sweden Small Cap rose 1.1% in August, positive contributions from Hansa Biopharma, Sinch and Paxman | FW |
Company Valuation: Getinge AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 107,613 | 58,914 | 61,092 | 49,449 | 59,594 | 64,225 | - | - |
| Change | - | -45.25% | 3.7% | -19.06% | 20.52% | 7.77% | - | - |
| Enterprise Value (EV) 1 | 111,222 | 61,516 | 69,104 | 59,916 | 69,434 | 72,426 | 70,182 | 67,682 |
| Change | - | -44.69% | 12.34% | -13.3% | 15.89% | 4.31% | -3.1% | -3.56% |
| P/E | 36.2x | 23.6x | 25.3x | 30.2x | 26.4x | 20.3x | 18.3x | 16.1x |
| PBR | 4.27x | 1.93x | 2.01x | 1.49x | 2.02x | 2x | 1.88x | 1.75x |
| PEG | - | -1.5x | -7.98x | -0.9x | 0.7x | 0.5x | 1.6x | 1.2x |
| Capitalization / Revenue | 3.98x | 2.08x | 1.92x | 1.42x | 1.7x | 1.82x | 1.72x | 1.64x |
| EV / Revenue | 4.11x | 2.17x | 2.17x | 1.72x | 1.99x | 2.05x | 1.88x | 1.73x |
| EV / EBITDA | 16.5x | 10.4x | 12.4x | 9.02x | 10.6x | 10.1x | 9.15x | 8.13x |
| EV / EBIT | 22.5x | 15x | 18.9x | 13.2x | 15.5x | 14.1x | 12.6x | 11.1x |
| EV / FCF | 19.8x | 32.4x | 43.1x | 18.3x | 26.4x | 18.3x | 17.5x | 15.2x |
| FCF Yield | 5.06% | 3.08% | 2.32% | 5.45% | 3.79% | 5.47% | 5.72% | 6.56% |
| Dividend per Share 2 | 4 | 4.25 | 4.4 | 4.6 | 4.75 | 5.174 | 5.612 | 6.011 |
| Rate of return | 1.01% | 1.96% | 1.96% | 2.53% | 2.17% | 2.19% | 2.38% | 2.55% |
| EPS 2 | 10.9 | 9.15 | 8.86 | 6.01 | 8.29 | 11.63 | 12.92 | 14.61 |
| Distribution rate | 36.7% | 46.4% | 49.7% | 76.5% | 57.3% | 44.5% | 43.4% | 41.2% |
| Net sales 1 | 27,049 | 28,292 | 31,827 | 34,759 | 34,969 | 35,261 | 37,238 | 39,053 |
| EBITDA 1 | 6,754 | 5,891 | 5,574 | 6,646 | 6,581 | 7,168 | 7,666 | 8,327 |
| EBIT 1 | 4,939 | 4,096 | 3,653 | 4,549 | 4,494 | 5,146 | 5,550 | 6,116 |
| Net income 1 | 2,970 | 2,491 | 2,412 | 1,638 | 2,258 | 3,166 | 3,527 | 3,986 |
| Net Debt 1 | 3,609 | 2,602 | 8,012 | 10,467 | 9,840 | 8,201 | 5,958 | 3,458 |
| Reference price 2 | 395.10 | 216.30 | 224.30 | 181.55 | 218.80 | 235.80 | 235.80 | 235.80 |
| Nbr of stocks (in thousands) | 272,370 | 272,370 | 272,370 | 272,370 | 272,370 | 272,370 | - | - |
| Announcement Date | 1/28/22 | 2/1/23 | 2/1/24 | 1/28/25 | 1/27/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 20.28x | 2.05x | 10.1x | 2.19% | 6.65B | |
| 72.06x | 7.58x | 44.19x | -.--% | 12.52B | |
| 35.13x | 1.75x | 10.94x | -.--% | 6.31B | |
| 27.28x | 5.62x | 15.21x | 1.4% | 5.57B | |
| 33.06x | 9.77x | 24.69x | 0.61% | 4.98B | |
| 17.29x | 2.88x | 14.99x | 3.6% | 3.77B | |
| -18.45x | 446.44x | -79.45x | -.--% | 1.82B | |
| -12.27x | 2.32x | -21.1x | - | 1.79B | |
| 18.37x | 2.25x | 8.48x | 2.2% | 1.59B | |
| 45.12x | 16.92x | 30.84x | 1.31% | 1.41B | |
| Average | 23.79x | 49.76x | 5.89x | 1.26% | 4.64B | |
| Weighted average by Cap. | 36.16x | 22.68x | 17.86x | 0.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GETI B Stock
- Valuation Getinge AB
Select your edition
All financial news and data tailored to specific country editions
